2005
DOI: 10.1111/j.1572-0241.2005.00244.x
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Tissue Transglutaminase Antibodies in Patients with Abnormal Liver Tests: Is It Always Coeliac Disease?

Abstract: The prevalence of CD in patients with chronically abnormal liver tests of unexplained etiology is 4%, with no relation with the degree of liver steatosis. Screening should be done by testing for IgA and IgG antibodies and then evaluating by endoscopy and biopsy only patients positive for both.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
42
1
3

Year Published

2006
2006
2012
2012

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 62 publications
(47 citation statements)
references
References 48 publications
1
42
1
3
Order By: Relevance
“…The liver blood test abnormalities observed in patients with nonalcoholic fatty liver disease and CD normalized after 6 months of a GFD. 74,75 The effect of a GFD on the reversal of histological abnormalities in nonalcoholic fatty liver disease remains to be elucidated.…”
Section: Nonalcoholic Fatty Liver Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…The liver blood test abnormalities observed in patients with nonalcoholic fatty liver disease and CD normalized after 6 months of a GFD. 74,75 The effect of a GFD on the reversal of histological abnormalities in nonalcoholic fatty liver disease remains to be elucidated.…”
Section: Nonalcoholic Fatty Liver Diseasementioning
confidence: 99%
“…74 Another study of 121 patients with biopsy-proven nonalcoholic fatty liver disease found that the prevalence of CD in patients with nonalcoholic fatty liver disease was 3.3%. 75 Impact of Gluten Withdrawal on Liver Disease. The liver blood test abnormalities observed in patients with nonalcoholic fatty liver disease and CD normalized after 6 months of a GFD.…”
Section: Nonalcoholic Fatty Liver Diseasementioning
confidence: 99%
“…Çölyak hastalarında tanı sırasında hastaların yaklaşık % 30'unda geçici transaminaz yükseklikleri olduğu bildirilmiştir [16,17]. Etyolojisi açıklanamayan kronik karaciğer enzim yüksekliği olan hastalarda sessiz çölyak hastalığı prevalansı ise yaklaşık % 4 olarak bildirilmiştir [18]. Karaciğer hasarı çoğunlukla hafif transaminaz yüksekliği ve karaciğer biyopsisinde nonspesifik bulgular ile kendini gösteren, "çölyak hepatiti" olarak da adlandırılan tablo ile kendini gösterir.…”
Section: Discussionunclassified
“…Due to the estimated high prevalence of CD in patients with cirrhosis that is higher than in the general population [8,16,29,30] , and the potential reversibility of liver dysfunction on a gluten free diet, we recommend prompt consideration and exclusion of SB mucosal diseases and CD (by using a combination of laboratory, clinical, pathologic and genetic examinations, and response to a gluten free diet), when shortened villi, reversal of villus to crypt ratio or villus atrophy are seen in patients with cirrhosis.…”
Section: Discussionmentioning
confidence: 99%
“…SB villus changes and atrophy are characteristic, but are not specific for coeliac disease [24,25] . Coeliac serological tests have low sensitivities and specificities in chronic liver disease and cirrhosis [15,[26][27][28][29] which emphasizes the importance of validating SB biopsy as the most important tool for the diagnosis of CD in this group of patients. Results of this study support the use of SB biopsy in patients with cirrhosis and portal hypertension when the diagnosis of CD is suspected.…”
Section: Discussionmentioning
confidence: 99%